Loading...
Wellbutrin (Bupropion)

Wellbutrin (Bupropion) Review

An antidepressant medication commonly used off-label for smoking cessation, containing the same active ingredient as Zyban.

3.8 out of 5 (156 reviews)

Manufacturer

GlaxoSmithKline

FDA Approved

1985 (for depression), Off-label for smoking cessation

Prescription Required

Yes

Generic Available

Yes

Typical Cost

$100-300 per month (brand name), $40-150 per month (generic)

Treatment Duration

7-12 weeks standard treatment

Overview of Wellbutrin (Bupropion)

Wellbutrin (bupropion hydrochloride) is primarily an antidepressant medication that has gained recognition for its effectiveness in smoking cessation. While not FDA-approved specifically for quitting smoking (unlike its chemical twin, Zyban), Wellbutrin is frequently prescribed off-label to help people quit tobacco.

Off-Label Use for Smoking Cessation

"Off-label" means prescribing a medication for a purpose other than what it was officially approved for. While Wellbutrin is FDA-approved for treating depression and seasonal affective disorder, many healthcare providers prescribe it for smoking cessation based on substantial evidence of its effectiveness for this purpose.

Wellbutrin contains the exact same active ingredient (bupropion hydrochloride) as Zyban, which is FDA-approved specifically for smoking cessation. The primary differences between the two are branding, marketing, and potentially insurance coverage.

Key Facts About Wellbutrin

  • Active ingredient: Bupropion hydrochloride
  • Drug class: Atypical antidepressant (aminoketone)
  • FDA approval: 1985 for depression, not specifically for smoking cessation
  • Available formulations: Immediate-release (IR), sustained-release (SR), and extended-release (XL)
  • Standard dosage for smoking cessation: 150 mg SR once daily for 3 days, then 150 mg SR twice daily
  • Treatment duration: 7-12 weeks is standard for smoking cessation
  • Prescription status: Requires a doctor's prescription
  • Available as generic: Yes (bupropion)

Wellbutrin offers a unique advantage for smokers who also experience depression or mood issues during the quitting process. Since it's an antidepressant, it can potentially address both smoking cessation and mood symptoms simultaneously.

Like Zyban, Wellbutrin is typically started 1-2 weeks before your target quit date to allow the medication to build up in your system. This approach helps reduce cravings and withdrawal symptoms by the time you stop smoking.

This review provides a comprehensive examination of Wellbutrin's effectiveness for smoking cessation, how it compares to Zyban and other quit methods, potential side effects, and whether it might be the right choice for your quit journey.

How Wellbutrin Works for Smoking Cessation

Wellbutrin (bupropion) works differently from other smoking cessation aids. Unlike nicotine replacement therapies that provide nicotine in controlled amounts, Wellbutrin is a non-nicotine medication that affects brain chemistry to help reduce cravings and withdrawal symptoms.

Mechanism of Action

Bupropion, the active ingredient in Wellbutrin, influences several brain processes relevant to both depression and nicotine addiction:

  • Dopamine and norepinephrine reuptake inhibition: Wellbutrin blocks the reabsorption of these neurotransmitters, increasing their levels in the brain
  • Nicotinic acetylcholine receptor antagonism: Bupropion blocks some of the same receptors that nicotine activates, potentially reducing the rewarding effects of smoking
  • Modulation of the brain's reward system: By affecting dopamine, which plays a key role in pleasure and reward, Wellbutrin helps reduce the pleasurable effects of smoking

These actions help address both the physical and psychological aspects of nicotine addiction, making it easier to quit smoking and stay quit.

Dual Benefits for Depression and Smoking Cessation

One of the unique advantages of Wellbutrin is its dual action on both depression and smoking cessation:

  • Addressing mood symptoms: Many smokers experience depression, irritability, or mood changes when quitting. Wellbutrin's antidepressant properties can help manage these symptoms
  • Reducing nicotine cravings: Independent of its antidepressant effects, Wellbutrin reduces the intensity and frequency of nicotine cravings
  • Minimizing withdrawal symptoms: The medication can help ease common withdrawal symptoms like irritability, anxiety, and difficulty concentrating
  • Weight management: Unlike some quit methods, Wellbutrin may help limit the weight gain that often occurs when quitting smoking

Wellbutrin Formulations and Smoking Cessation

Wellbutrin comes in three different formulations, but not all are equally suitable for smoking cessation:

FormulationRelease PatternRecommended for Smoking CessationNotes
Wellbutrin IR (Immediate Release)Releases quickly, taken 3 times dailyNoHigher risk of seizures, less convenient dosing
Wellbutrin SR (Sustained Release)Releases over 12 hours, taken twice dailyYesSame formulation as Zyban, most studied for smoking cessation
Wellbutrin XL (Extended Release)Releases over 24 hours, taken once dailySometimesLess studied for smoking cessation, but may be used for convenience

Note: Wellbutrin SR is chemically identical to Zyban and is the formulation most commonly prescribed for smoking cessation.

Unlike nicotine replacement therapies that provide immediate relief from withdrawal symptoms, Wellbutrin requires time to build up in your system. This is why it's typically started 1-2 weeks before your quit date. This gradual onset helps your brain adjust to the medication and prepares you for your quit attempt.

Effectiveness & Success Rates

Since Wellbutrin contains the same active ingredient (bupropion) as Zyban, its effectiveness for smoking cessation is virtually identical. The research on bupropion for smoking cessation is extensive and shows consistent benefits compared to placebo.

Clinical Evidence

Multiple clinical trials and meta-analyses have evaluated bupropion's effectiveness for smoking cessation:

  • Abstinence rates: 16-30% for bupropion users compared to 8-15% for placebo after 12 weeks of treatment
  • Long-term success: 14-16% of bupropion users remained smoke-free at one year, compared to 4-9% with placebo
  • Effectiveness ratio: Bupropion approximately doubles a smoker's chances of successfully quitting compared to placebo
  • Reduced cravings: Studies show significant reduction in nicotine cravings and withdrawal symptoms

Effectiveness in Special Populations

Research has shown that bupropion may be particularly effective for certain groups:

  • Smokers with depression: Bupropion can address both depression symptoms and smoking cessation needs simultaneously
  • People concerned about weight gain: Bupropion is associated with less weight gain after quitting compared to other methods
  • Heavy smokers: Those who smoke more than a pack per day may benefit from bupropion's effects on reducing cravings
  • Smokers who have failed with nicotine replacement therapy: Bupropion works through different mechanisms and may help those who didn't succeed with NRT

Comparison with Other Cessation Methods

TreatmentShort-term Success RateLong-term Success Rate (1 year)
Wellbutrin/Zyban (bupropion)16-30%14-16%
Chantix (varenicline)22-44%19-22%
Nicotine Patch19-26%10-14%
Nicotine Gum17-24%8-12%
Cold Turkey3-5%2-3%

Source: Data compiled from multiple clinical studies and meta-analyses published between 1997-2024.

Wellbutrin vs. Zyban Effectiveness

Since Wellbutrin SR and Zyban contain identical active ingredients in the same formulation:

  • Equal efficacy: Clinical effectiveness for smoking cessation is identical
  • Same side effect profile: Both medications carry the same potential side effects and warnings
  • Identical dosing: The recommended dosing schedule for smoking cessation is the same
  • Main differences: Branding, marketing, and potentially insurance coverage (some plans may cover one but not the other)

Factors Affecting Success

Several factors can influence how effective Wellbutrin will be for an individual:

  • Adherence to treatment: Taking Wellbutrin consistently as prescribed significantly improves success rates
  • Treatment duration: Completing the full 7-12 week course is important for long-term success
  • Behavioral support: Combining Wellbutrin with counseling or behavioral therapy can increase success rates by 10-15%
  • Motivation level: Higher motivation to quit is associated with better outcomes
  • Previous quit attempts: Success rates may be lower for those who have tried and failed multiple times before
  • Presence of depression: Those with depression symptoms may see additional benefits from Wellbutrin's antidepressant effects

Side Effects & Safety

As with all prescription medications, Wellbutrin (bupropion) can cause side effects. Since it's identical to Zyban, the side effect profile is the same for both medications when used for smoking cessation.

Common Side Effects

The following side effects occur in more than 5% of patients:

  • Insomnia: Difficulty sleeping affects 30-40% of users, often more pronounced early in treatment
  • Dry mouth: Reported by 10-15% of patients
  • Headache: Occurs in about 25% of users
  • Nausea: Affects 10-15% of patients
  • Dizziness: Experienced by 8-12% of users
  • Anxiety or agitation: Reported by 5-10% of patients
  • Constipation: Affects 5-10% of users

Most of these side effects are mild to moderate and often decrease over time as your body adjusts to the medication. Taking Wellbutrin in the morning (and the second dose, if applicable, no later than mid-afternoon) can help reduce insomnia.

Serious Side Effects

Though less common, some serious side effects require immediate medical attention:

  • Seizures: The risk is about 0.1% (1 in 1,000) at the recommended dose for smoking cessation
  • Neuropsychiatric symptoms: Changes in behavior, agitation, depressed mood, suicidal thoughts or actions (rare but serious)
  • Allergic reactions: Skin rash, itching, hives, swelling (rare)
  • Hypertension: Elevated blood pressure has been reported in some patients
  • Angle-closure glaucoma: Very rare but can occur in susceptible individuals

FDA Black Box Warning

Wellbutrin carries an FDA black box warning (the most serious type of warning) regarding the risk of suicidal thoughts and behaviors, particularly in children, adolescents, and young adults up to age 24, especially during the first few weeks of treatment.

While this risk is primarily associated with its use as an antidepressant, healthcare providers should monitor all patients taking Wellbutrin for worsening depression or unusual changes in behavior, regardless of the reason it's prescribed.

Risk Factors for Seizures

The risk of seizures with Wellbutrin is dose-dependent and increases with certain factors:

  • History of seizures or epilepsy
  • History of head trauma or brain injury
  • Central nervous system tumors
  • Eating disorders (anorexia, bulimia)
  • Abrupt discontinuation of alcohol, benzodiazepines, or seizure medications
  • Use of other medications that lower seizure threshold
  • Excessive use of stimulants (including caffeine)
  • Diabetes treated with oral hypoglycemics or insulin

Who Should Not Take Wellbutrin

Wellbutrin is contraindicated (should not be used) in people with:

  • Current or prior diagnosis of seizure disorder or epilepsy
  • Current or prior diagnosis of bulimia or anorexia nervosa
  • Undergoing abrupt discontinuation of alcohol, benzodiazepines, or seizure medications
  • Taking a monoamine oxidase inhibitor (MAOI) currently or within the past 14 days
  • Known hypersensitivity to bupropion or any components of Wellbutrin
  • Taking other medications containing bupropion (to avoid overdose)

Drug Interactions

Wellbutrin can interact with many medications. Some of the most significant interactions include:

  • MAO inhibitors: Can cause serious, potentially fatal reactions
  • Other antidepressants: May increase risk of serotonin syndrome or seizures
  • Antipsychotics: May increase risk of seizures
  • Theophylline: Bupropion may increase theophylline levels
  • Tamoxifen: Bupropion may reduce tamoxifen's effectiveness
  • Alcohol: May increase neuropsychiatric adverse effects
  • Drugs metabolized by CYP2D6: Bupropion inhibits this enzyme, potentially increasing levels of these drugs

Always provide your healthcare provider with a complete list of all medications, supplements, and herbal products you're taking before starting Wellbutrin.